Laboratorios Farmaceúticos Rovi SA

48
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0157261019
EUR
62.25
0.4 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
763.00
829.00
817.00
648.00
419.00
381.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
763.00
829.00
817.00
648.00
419.00
381.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
135.00
122.00
106.00
89.00
74.00
72.00
Operating Expenses
2.00
0.00
0.00
0.00
1.00
0.00
General and Administration Expenses
236.00
213.00
213.00
148.00
113.00
120.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
576.00
604.00
558.00
461.00
335.00
334.00
Operating Profit (PBDIT) excl Other Income
187.00
225.00
259.00
187.00
84.00
46.00
Other Income
1.00
1.00
4.00
2.00
1.00
1.00
Operating Profit (PBDIT)
208.00
245.00
281.00
205.00
98.00
61.00
Interest
2.00
0.00
0.00
0.00
1.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
28.00
24.00
22.00
21.00
19.00
18.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
177.00
220.00
257.00
182.00
72.00
42.00
Provision for Tax
40.00
50.00
58.00
29.00
11.00
2.00
Profit After Tax
136.00
170.00
199.00
153.00
61.00
39.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.68
3.29
3.73
2.76
1.10
0.71
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -7.93% vs 1.44% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -16.67% vs -13.05% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 147.89% vs 11.66% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -19.64% vs -14.69% in Dec 2023

Compare Profit and Loss Results of Laboratorios Farmaceúticos Rovi SA
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
No of Months
12
12
Operating Income
763.00
7,212.00
-6,449.00
-89.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
763.00
7,212.00
-6,449.00
-89.42%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
135.00
2,052.00
-1,917.00
-93.42%
Operating Expenses
2.00
714.00
-712.00
-99.72%
General and Administration Expenses
236.00
1,144.00
-908.00
-79.37%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
576.00
6,057.00
-5,481.00
-90.49%
Operating Profit (PBDIT) excl Other Income
187.00
1,155.00
-968.00
-83.81%
Other Income
1.00
-13.00
14.00
107.69%
Operating Profit (PBDIT)
208.00
1,549.00
-1,341.00
-86.57%
Interest
2.00
714.00
-712.00
-99.72%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
28.00
437.00
-409.00
-93.59%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
177.00
407.00
-230.00
-56.51%
Provision for Tax
40.00
231.00
-191.00
-82.68%
Profit After Tax
136.00
156.00
-20.00
-12.82%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.6761
0.2306
2.45
1,060.49%
Profit And Loss - Net Sales
Net Sales 763.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -7.93% vs 1.44% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 187.68 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.67% vs -13.05% in Dec 2023

Profit And Loss - Interest
Interest 2.35 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 147.89% vs 11.66% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 136.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -19.64% vs -14.69% in Dec 2023